OCT-Derived Radiomic Features Predict Anti-VEGF Response and Durability in Neovascular Age-Related Macular Degeneration

被引:11
作者
Kar, Sudeshna Sil [1 ,2 ]
Cetin, Hasan [1 ]
Lunasco, Leina [1 ]
Le, Thuy K. [1 ]
Zahid, Robert [3 ]
Meng, Xiangyi [3 ]
Srivastava, Sunil K. [1 ,4 ]
Madabhushi, Anant [2 ,5 ]
Ehlers, Justis P. [1 ,4 ,6 ]
机构
[1] Cleveland Clin, Cole Eye Inst, Tony & Leona Campane Ctr Excellence Image Guided S, Cleveland, OH USA
[2] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH USA
[3] Novartis Pharmaceut, E Hanover, NJ USA
[4] Cleveland Clin, Cole Eye Inst, Vitreoretinal Serv, Cleveland, OH USA
[5] Louis Stokes Cleveland Vet Adm Med Ctr, Cleveland, OH USA
[6] Cleveland Clin, Cole Eye Inst, 9500 Euclid Ave,Desk i32, Cleveland, OH 44195 USA
来源
OPHTHALMOLOGY SCIENCE | 2022年 / 2卷 / 04期
基金
美国国家卫生研究院;
关键词
OCT; Radiomics; Wet age-related macular degeneration; VISUAL-ACUITY; RANIBIZUMAB; THERAPY; AFLIBERCEPT;
D O I
10.1016/j.xops.2022.100171
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: No established biomarkers currently exist for therapeutic efficacy and durability of anti-VEGF therapy in neovascular age-related macular degeneration (nAMD). This study evaluated radiomic-based quanti-tative OCT biomarkers that may be predictive of anti-VEGF treatment response and durability.Design: Assessment of baseline biomarkers using machine learning (ML) classifiers to predict tolerance to anti-VEGF therapy. Participants: Eighty-one participants with treatment-naive nAMD from the OSPREY study, including 15 super responders (patients who achieved and maintained retinal fluid resolution) and 66 non -super responders (patients who did not achieve or maintain retinal fluid resolution).Methods: A total of 962 texture-based radiomic features were extracted from fluid, subretinal hyperreflective material (SHRM), and different retinal tissue compartments of OCT scans. The top 8 features, chosen by the minimum redundancy maximum relevance feature selection method, were evaluated using 4 ML classifiers in a cross-validated approach to distinguish between the 2 patient groups. Longitudinal assessment of changes in different texture-based radiomic descriptors (delta-texture features) between baseline and month 3 also was performed to evaluate their association with treatment response. Additionally, 8 baseline clinical parameters and a combination of baseline OCT, delta-texture features, and the clinical parameters were evaluated in a cross -validated approach in terms of association with therapeutic response.Main Outcome Measures: The cross-validated area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, and specificity were calculated to validate the classifier performance.Results: The cross-validated AUC by the quadratic discriminant analysis classifier was 0.75 & PLUSMN; 0.09 using texture-based baseline OCT features. The delta-texture features within different OCT compartments between baseline and month 3 yielded an AUC of 0.78 & PLUSMN; 0.08. The baseline clinical parameters sub -retinal pigment epithelium volume and intraretinal fluid volume yielded an AUC of 0.62 & PLUSMN; 0.07. When all the baseline, delta, and clinical features were combined, a statistically significant improvement in the classifier performance (AUC, 0.81 & PLUSMN; 0.07) was obtained.Conclusions: Radiomic-based quantitative assessment of OCT images was shown to distinguish between super responders and non -super responders to anti-VEGF therapy in nAMD. The baseline fluid and SHRM delta -texture features were found to be most discriminating across groups. Ophthalmology Science 2022;2:100171 & COPY; 2022 by the American Academy of Ophthalmology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:12
相关论文
共 44 条
  • [1] CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING
    BENJAMINI, Y
    HOCHBERG, Y
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) : 289 - 300
  • [2] Prediction of Anti-VEGF Treatment Requirements in Neovascular AMD Using a Machine Learning Approach
    Bogunovic, Hrvoje
    Waldstein, Sebastian M.
    Schlegl, Thomas
    Langs, Georg
    Sadeghipour, Amir
    Liu, Xuhui
    Gerendas, Bianca S.
    Osborne, Aaron
    Schmidt-Erfurth, Ursula
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (07) : 3240 - 3248
  • [3] Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI
    Braman, Nathaniel M.
    Etesami, Maryam
    Prasanna, Prateek
    Dubchuk, Christina
    Gilmore, Hannah
    Tiwari, Pallavi
    Pletcha, Donna
    Madabhushi, Anant
    [J]. BREAST CANCER RESEARCH, 2017, 19
  • [4] Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD
    Chakravarthy, Usha
    Havilio, Moshe
    Syntosi, Annie
    Pillai, Natasha
    Wilkes, Emily
    Benyamini, Gidi
    Best, Catherine
    Sagkriotis, Alexandros
    [J]. EYE, 2021, 35 (11) : 2983 - 2990
  • [5] GOOD VISUAL OUTCOME AT 1 YEAR IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH PIGMENT EPITHELIUM DETACHMENT Factors Influencing the Treatment Response
    de Massougnes, Sophie
    Dirani, Ali
    Mantel, Irmela
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (04): : 717 - 724
  • [6] Quantitative SD-OCT Imaging Biomarkers as Indicators of Age-Related Macular Degeneration Progression
    de Sisternes, Luis
    Simon, Noah
    Tibshirani, Robert
    Leng, Theodore
    Rubin, Daniel L.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (11) : 7093 - 7103
  • [7] HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
    Dugel, Pravin U.
    Koh, Adrian
    Ogura, Yuichiro
    Jaffe, Glenn J.
    Schmidt-Erfurth, Ursula
    Brown, David M.
    Gomes, Andre, V
    Warburton, James
    Weichselberger, Andreas
    Holz, Frank G.
    [J]. OPHTHALMOLOGY, 2020, 127 (01) : 72 - 84
  • [8] Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial
    Dugel, Pravin U.
    Jaffe, Glenn J.
    Sallstig, Peter
    Warburton, James
    Weichselberger, Andreas
    Wieland, Mark
    Singerman, Lawrence
    [J]. OPHTHALMOLOGY, 2017, 124 (09) : 1296 - 1304
  • [9] Response Estimation Through Spatially Oriented Neural Network and Texture Ensemble (RESONATE)
    Eben, Jeffrey E.
    Braman, Nathaniel
    Madabhushi, Anant
    [J]. MEDICAL IMAGE COMPUTING AND COMPUTER ASSISTED INTERVENTION - MICCAI 2019, PT IV, 2019, 11767 : 602 - 610
  • [10] Longitudinal Higher-Order OCT Assessment of Quantitative Fluid Dynamics and the Total Retinal Fluid Index in Neovascular AMD
    Ehlers, Justis P.
    Clark, Julie
    Uchida, Atsuro
    Figueiredo, Natalia
    Babiuch, Amy
    Talcott, Katherine E.
    Lunasco, Leina
    Le, Thuy K.
    Meng, Xiangyi
    Hu, Ming
    Reese, Jamie
    Srivastava, Sunil K.
    [J]. TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2021, 10 (03):